Results 141 to 150 of about 47,993 (230)
LKB1–AMPK Signaling Pathway in Cardiovascular and Other Diseases
The LKB1–AMPK pathway has a central regulatory role in various diseases. Dysfunction of this pathway can lead to pathological processes in cardiovascular diseases (atrial fibrillation, myocardial infarction, myocardial hypertrophy, atherosclerosis), metabolic diseases (diabetes and kidney disease), neurodegenerative diseases (Alzheimer's disease ...
Zhuo Chen, Qin Yang, Guo‐Wei He
wiley +1 more source
Orthognathic Surgical Outcomes in Patients With and Without Craniofacial Anomalies [PDF]
Purpose The objective of this study is to examine hospitalization outcomes after orthognathic surgery. This study tests the hypothesis that patients with craniofacial anomalies have higher billed hospital charges, longer lengths of stay, and increased ...
Allareddy, Veerasathpurush +3 more
core +1 more source
Our findings indicate that a pediatric/AYA‐specific targeted panel deployed in a hospital can deliver rapid, clinically actionable molecular insights with high diagnostic and prognostic yield. This complements larger sequencing platforms by offering speed, focused content, and easier interpretation.
Masato Kojima +8 more
wiley +1 more source
ENFERMEDAD DE VON RECKLINGHAUSEN Y EMBARAZO
La enfermedad de Von Recklinghausen (neurofibromatosis) es una condición autosómica dominante la cual ha tenido variables expresiones clínicas, con manifestaciones que van de lesiones cutáneas moderadas a complicaciones ortopédicas severas y alteraciones
Gregorio Evans M. +2 more
doaj
Current progress in genomics and targeted therapies for neurofibromatosis type 2. [PDF]
Hiruta R, Saito K, Bakhit M, Fujii M.
europepmc +1 more source
Case report of selumetinib as a novel therapy in a neurofibromatosis type 2-associated ependymoma. [PDF]
Blackwood N, Zetzmann C, Trevino CR.
europepmc +1 more source

